drug
as of 2026-07-01Curcumin
MeSH D003474
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Beersheva Mental Health Center
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
3
Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia
NCT07523256—Completed
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
NCT02298985Phase 4Completed
Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia
NCT02104752Phase 1, Phase 2Completed
KOLs & investigators
4
Stephen J Heishman, Ph.D.KOL score 5
Jonathan K Wynn, Ph.D.KOL score 5
Prof. Vladimir Lerner, MD, PhDKOL score 5
Michael C Davis, M.D., Ph.D.KOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
KOL
Stephen J Heishman, Ph.D.
personKOL score 5
Jonathan K Wynn, Ph.D.
personKOL score 5
Prof. Vladimir Lerner, MD, PhD
personKOL score 5
Michael C Davis, M.D., Ph.D.
personKOL score 5